BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peixoto R, Pereira ML, Oliveira M. Beta-Blockers and Cancer: Where Are We? Pharmaceuticals (Basel) 2020;13:E105. [PMID: 32466499 DOI: 10.3390/ph13060105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Farhoumand LS, Fiorentzis M, Kraemer MM, Sak A, Stuschke M, Rassaf T, Hendgen-cotta U, Bechrakis NE, Berchner-pfannschmidt U. The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation. Cancers 2022;14:3097. [DOI: 10.3390/cancers14133097] [Reference Citation Analysis]
2 Farhan HA, Yaseen IF. Perceptions of the Cardiologists and Oncologists: Initial Step for Establishing Cardio-Oncology Service. Front Cardiovasc Med 2021;8:704029. [PMID: 34917654 DOI: 10.3389/fcvm.2021.704029] [Reference Citation Analysis]
3 Liu HM, Ma LL, Li C, Cao B, Jiang Y, Han L, Xu R, Lin J, Zhang D. The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy. Transl Oncol 2022;15:101281. [PMID: 34875482 DOI: 10.1016/j.tranon.2021.101281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wackerhage H, Christensen JF, Ilmer M, von Luettichau I, Renz BW, Schönfelder M. Cancer catecholamine conundrum. Trends Cancer 2021:S2405-8033(21)00210-7. [PMID: 34776398 DOI: 10.1016/j.trecan.2021.10.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Carlos-Escalante JA, de Jesús-Sánchez M, Rivas-Castro A, Pichardo-Rojas PS, Arce C, Wegman-Ostrosky T. The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer. Front Oncol 2021;11:660943. [PMID: 34094953 DOI: 10.3389/fonc.2021.660943] [Reference Citation Analysis]
6 Chen M, Singh AK, Repasky EA. Highlighting the Potential for Chronic Stress to Minimize Therapeutic Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance. Cancers (Basel) 2020;12:E3853. [PMID: 33419318 DOI: 10.3390/cancers12123853] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Sakakitani S, Podyma-Inoue KA, Takayama R, Takahashi K, Ishigami-Yuasa M, Kagechika H, Harada H, Watabe T. Activation of β2-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells. Cancer Sci 2021;112:155-67. [PMID: 33007125 DOI: 10.1111/cas.14670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]